Ten Ethical Flaws in the Caster Semenya Decision on Intersex in Sport
May 13, 2019
(The Conversation) – Middle-distance runner Caster Semenya will need to take hormone-lowering agents, or have surgery, if she wishes to continue her career in her chosen athletic events. The Court of Arbitration in Sport (CAS) decided last week to uphold a rule requiring athletes with certain forms of what they call “disorders of sex development” (DSD) – more commonly called “intersex” conditions – to lower their testosterone levels in order to still be eligible to compete as women in certain elite races. The case was brought to CAS by Semenya, as she argued discrimination linked to a 2018 decision preventing some women, including herself, from competing in some female events. This ruling is flawed. On the basis of science and ethical reasoning, there are ten reasons CAS’s decision does not stand up.